Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q34601624
Magnetic susceptibility as a B0 field strength independent MRI biomarker of liver iron overloadAtherogenesis and iron: from epidemiology to cellular level.Association of iron overload based quantitative T2* MRI technique and carotid intima-media thickness in patients with beta-thalassemia: a cross-sectional study.Clinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemiaThe Role of the Carotid Doppler Examination in the Evaluation of Atherosclerotic Changes in β-Thalassemia PatientsThalassemia Major in Adults: Short Stature, Hyperpigmentation, Inadequate Chelation, and Transfusion-Transmitted Infections are Key Features.Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveIron chelation therapy for patients with myelodysplastic syndrome.Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.Cost-utility of chelators in transfusion-dependent β-thalassemia major patients: a review of the pharmacoeconomic literature.Long-term chelation therapy with deferasirox: effects on cardiac iron overload measured by T2* MRI.Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease.Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ß-thalassemia in upper Egypt (single center study).
P2860

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q34601624
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Deferasirox for the treatment ...... eview and economic evaluation.
@ast
Deferasirox for the treatment ...... eview and economic evaluation.
@en
Deferasirox for the treatment of iron overload associated with regular blood transfusions
@nl
type
label
Deferasirox for the treatment ...... eview and economic evaluation.
@ast
Deferasirox for the treatment ...... eview and economic evaluation.
@en
Deferasirox for the treatment of iron overload associated with regular blood transfusions
@nl
prefLabel
Deferasirox for the treatment ...... eview and economic evaluation.
@ast
Deferasirox for the treatment ...... eview and economic evaluation.
@en
Deferasirox for the treatment of iron overload associated with regular blood transfusions
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Deferasirox for the treatment ...... eview and economic evaluation.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698